University of Pittsburgh Seal Link to Homepage
Archive Service Center Link University Library System Link

Tissue Matching Appendix

# Article Information # of Cites
1Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI: Shwartzman reaction after human renal transplantation. N Engl J Med 278:642-648, 1968.
2Terasaki PI, Marchioro TL, Starzl TE: Sero-typing of human lymphocyte antigens: Preliminary trials on long-term kidney homograft survivors. In: Histocompatibility Testing National Acad Sci-National Res Council, Washington, DC, 1965, pp. 83-96
3Starzl TE, Porter KA, Andres G, Halgrimson CG, Hurwitz R, Giles G, Terasaki PI, Penn I, Schroter GT, Lilly J, Starkie SJ, Putnam CW: Long-term survival after renal transplantation in humans: With special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG, and recipient malignancy. Ann Surg 172:437-472, 1970.
4Starzl TE, Marchioro TL, Waddell WR: Human renal homotransplantation in the presence of blood group incompatibilities. Proc Soc Exp Biol Med 113:471-472, 1963.
5Gordon RD, Iwatsuki S, Esquivel CO, Todo S, Makowka L, Tzakis A, Marsh JW, Starzl TE: Experience with primary liver transplantation across ABO blood groups. Transplant Proc 19:179-183, 1987.
6Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M< Klintmalm G, Bryan C, Van Thiel DH, Starzl TE: Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 46:372-377, 1988.
7Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE: The antibody crossmatch in liver transplantation. Surgery 100:705-715, 1986.
8Ramsey G, Nusbacher J, Starzl TE, Lindsay GD: Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. New Engl J Med 311:1167-1170, 1984.
9Zeevi A, Duquesnoy R, Eiras G, Rabinowich H, Todo S, Makowka L, Starzl TE: Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: Synergism with cyclosporine A. Transplant Proc 19:40-44, 1987.
10Demetris JA, Lasky S, Van Thiel DH, Starzl TE, Whiteside T: Induction of DR/Ia antigens in human liver allografts: An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation 40:504-509, 1985.
11Cramer DV, Qian S, Harnaha J, Chapman F, Estes LW, Starzl TE, Makowka L: Cardiac transplantation in the rat. Transplantation 47(3):414-419, 1989.
12Iwatsuki S, Iwaki Y, Kano T, Klintmalm G, Koep LJ, Weil R, Starzl TE: Successful liver transplantation from crossmatch-positive donors. Transplant Proc 13:286-288, 1981.
13Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, Demetris AJ, Kobayashi M, Todo S, Tzakis AG, Fung JJ, Starzl TE: The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 53:400-406, 1992.
14Iwatsuki S, Rabin BS, Shaw BW Jr, Starzl TE: Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 16:1427-1429, 1984.
15Todo S, Podesta L, ChapChap P, Kahn D, Pan C-E, Ueda Y, Okuda K, Imventarza O, Casavilla A, Demetris AJ, Makowka L, Starzl TE: Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc 19:64-67, 1987.
16Starzl TE, Hakala TR, Rosenthal JT, Iwatsuki S, Shaw BW Jr: The Colorado-Pittsburgh cadaveric renal transplantation study with cyclosporine. Transplant Proc 15:2459-2462, 1983.
17Simpson KM, Bunch DL, Amemiya H, Boehmig HJ, Wilson CB, Dixon FJ, Coburg AJ, Hathaway WE, Giles GR, Starzl TE: Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery 68:77-85, 1970.
18Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, Demetris AJ, Van Thiel DH, Starzl TE, Duquesnoy RJ: The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 55:1067-1071, 1993.
19Starzl TE, Demetris AJ, Todo S, Kang Y, Tzakis A, Duquesnoy R, Makowka L, Banner B, Concepcion W, Porter KA: Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant 3(1):37-45, 1989.
20Demetris AJ, Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartmann GG, Murase N, Bronsther O, Manez R, Fung JJ, Iwatsuki S, Starzl TE: A clinicopathological study of human liver allograft recipients harboring IgG lymphocytotoxic antibodies. Hepatology 16:671-681, 1992.
21Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ: The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 59(4):640-642, 1995.
22Doyle HR, Marino IR, Morelli F, Doria C, Aldrighetti L, McMichael J, Martell J, T Gayowski, Starzl TE: Assessing risk in liver transplantation - with special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 224(2):168-177, 1996.
23Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ: Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 13:239-246, 1991.
24Duquesnoy RJ, White LT, Fierst JW, Vanek M, Banner B, Iwaki Y, Starzl TE: Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private Class I HLA determinants: Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation. Transplantation 50:427-437, 1990.
25Takaya S, Iwaki Y, Starzl TE: Liver Transplantation in positive cytotoxic crossmatch cases using FK506, high dose steroids and prostaglandin E1. Transplantation 54:927-929, 1992.
26Weil R III, Clarke DR, Iwaki Y, Porter KA, Koep LJ, Paton BC, Terasaki PI, Starzl TE: Hyperacute rejection of a transplanted human heart. Transplantation 32:71-72, 1981.
27Starzl TE, Penn I, Halgrimson CT: Immunosuppression and malignant neoplasms. N Engl J Med 283:934-935, 1970.
28Starzl TE: History of Clinical Transplantation. World J Surg 24:759-782, 2000. (Also published verbatim in: Starzl TE: A History of Clinical Transplantation. In: Surgery: Basic Science and Clinical Evidence. (eds. JA Norton, R Bollinger, AE Chang, SJ Mulvihill, S Lowry, H Pass, R Thompson). Springer Verlag, New York, NY. 2001 and 2008, 1st and 2nd editions).
29Terasaki PI, Vredevoe DL, Mickey MR, Porter KA, Marchioro TL, Faris TD, Starzl TE: Serotyping for homotransplantation. VI. Selection of kidney donors for thirty-two recipients. Ann NY Acad Sci 129:500-520, 1966.
30Ogden DA, Porter KA, Terasaki PI, Marchioro TL, Holmes JH, Starzl TE: Chronic renal homograft function: Correlation with histology and lymphocyte antigen matching. Am J Med 43:837-845, 1967.
31Takaya S, Duquesnoy R, Iwaki Y, Demetris J, Yagihashi A, Bronsther O, Iwatsuki S, Starzl TE: Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc 23:396-399, 1991.
32Gordon RD, Iwatsuki S, Esquivel CO, Todo S, Makowka L, Tzakis A, Marsh JW, Starzl TE: Experience with primary liver transplantation across ABO blood groups. Transplant Proc 19:179-183, 1987.
33Starzl TE, Eliasziw M, Gjertson M, Terasaki PI, Fung JJ, Trucco M, Martell J, McMichael J, Shapiro R, Donner A: HLA and cross reactive antigen group (CREG) matching for cadaver kidney allocation. Transplantation 64:983-991, 1997.
34Ramsey G, Cornell FW, Hahn LF, Larson P, Issitt LB, Starzl TE: Red cell antibody problems in 1000 liver transplants. Transfusion 29:396-400, 1989.
35Salamon DJ, Ramsey G, Nusbacher J, Yang S, Starzl TE, Israel L: Anti-A production by a group O spleen transplanted to a group A recipient. Vox Sang 48:309-312, 1985.
36Qian S, Fu F, Li Y, Rao AS, Starzl TE, Thomson AW, Fung JJ: Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology 88:124-129, 1996.
37Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S, Esquivel C, Shapiro R, Zjako A, Markus B, Morozec E, Van Thiel DH, Sysyn G, Gordon R, Makowka L, Starzl TE: Antibody mediated rejection of human liver allografts: Transplantation across ABO blood group barriers. Transplant Proc 21:2217-2220, 1989.
38Weber T, Marino IR, Kang YG, Esquivel CO, Starzl TE, Duquesnoy RJ: Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 47(5):797-801, 1989.
39Boehmig HJ, Giles GR, Amemiya H, Wilson CB, Coburg AJ, Genton E, Bunch DL, Dixon FJ, Starzl TE: Hyperacute rejection of renal homografts: With particular reference to coagulation changes, humoral antibodies, and formed blood elements. Transplant Proc 3:1105-1117, 1971.
40Manez R, Kelly RH, Kobayashi M, Takaya S, Bronsther S, Kramer D, Duquesnoy RJ, Iwaki Y, Fung JJ, Starzl TE, Demetris AJ: IgG lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance. Hepatology 21:1345-1352, 1995.
41Ramsey G, Hahn LF, Cornell FW, Boczkowski DJ, Staschak S, Clark R, Hardesty RL, Griffith BP, Starzl TE: Low rate of Rhesus immunization from RH-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 47:993-995, 1989.
42Scantlebury V, Gjertson D, Eliasziw M, Terasaki P, Fung J, Shapiro R, Donner A, Starzl TE: The effect of HLA mismatch in African-Americans. Transplantation 65:586-588, 1998.
43Cramer DV, Qian S, Harnaha J, Chapman FA, Starzl TE, Makowka L: Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes. Transplant Proc 21:3714-3715, 1989.
44Furuya T, Murase N, Nakamura K, Woo J, Todo S, Demetris AJ, Starzl TE: Preformed lymphocytotoxic antibodies: The effects of class, titer and specificity on liver versus heart allografts. Hepatology 16:1415-1422, 1992.
45Leung PSC, Krams S, Munoz S, Surh CP, Ansari A, Kenny T, Robbins DL, Fung J, Starzl TE, Maddrey W, Coppel RL, Gershwin ME: Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis. J Autoimmunity 5:703-718, 1992.
4644. Groth CG, Brent LB, Calne RY, Dausset JB, Good RA, Murray JE, Shumway NE, Schwartz RS, Starzl TE, Terasaki PI, Thomas ED, van Rood JJ: Historical landmarks in clinical transplantation: conclusions from the concensus conference at the University of California, Los Angeles (UCLA). World J Surg 24:834-843, 2000.
47Yagihashi A, Kobayashi M, Noguchi K, Konno A, Yoshida Y, Terasawa K, Starzl TE, Iwaki Y: HLA matching effect in liver transplantation. Transplant Proc 24:2432-2433, 1992.
48Subbotin V, Sun H, Aitouche A, Salam A, Valdivia LA, Fung JJ, Starzl TE, Rao AS: Marked mitigation of transplant vascular scerlosis in FasLgld (CD95L) mutant recipients: The role of alloantibodies in the development of chronic rejection. Transplantation 67:1295-1300, 1999.
49Bond G, Reyes J, Mazariegos G, Wu T, Schaefer N, Demetris J, Fung JJ, Starzl TE, Abu-Elmagd K: The impact of positive T-cell lymphocytotoxic cross-match on intestinal allograft rejection and survival. Transplant Proc 32:1197-1198, 2000.
50Noguchi K, Kobayashi M, Yagihashi A, Yoshida Y, Terasawa K, Konno A, Ichida F, Venek M, Iwatsuki S, Starzl TE, Iwaki Y: HLA antigens in primary sclerosing cholangitis. Transplant Proc 24:2775-2776, 1992.
51Tanabe M, Murase N, Demetris AJ, Hoffman RA, Nakamura K, Fujisaki S, Galvao FHF, Todo S, Fung J, Starzl TE: The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc 26(6):4325-4332, 1994.
52Halgrimson CG, Rapaport FT, Terasaki PI, Porter KA, Andres G, Penn I, Putnam CW, Starzl TE: Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc 3:140-144, 1971.
53Markus BH, Fung JJ, Gordon RD, Vanek M, Starzl TE, Duquesnoy RJ: HLA histocompatibility and liver transplant survival. Transplant Proc 19:63-65, 1987.
54Scantlebury V, Gjertson D, Eliasziw M, Terasaki P, Fung J, Shapiro R, Donner A, Starzl TE: The influence of HLA and CREG matching in African-American primary cadaver kidney recipients - UNOS 1991-1995. Transplant Proc 29:3733-3736, 1997.
55Corman JL, Kashiwagi N, Porter KA, Andres G, Iwatsuki S, Putnam CW, Popovtzer M, Penn I, Starzl TE: Unsuccessful attempts to control hyperacute rejection of human renal homografts with F (ab')2 and citrate organ pretreatment. Transplantation 16:60-63, 1973.
56Starzl TE, Rao AS, Trucco M, Fontes P, Fung JJ, Demetris AJ: Explanation for loss of the HLA matching effect. Transplant Proc 27:57-60, 1995.
57Starzl TE, Marchioro TL, Waddell WR: Human renal homotransplantation in the presence of blood group incompatibilities. Proc Soc Exp Biol Med 113:471-472, 1963.
58Takaya S, Jain A, Yagihashi A, Nakamura K, Kobayashi M, Takeuchi K, Suzuki S, Iwaki Y, Demetris AJ, Todo S, Starzl TE: Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc 31:2028-2031, 1999.
59Banner B, Makowka L, Demetris J, Tzakis A, Griffin M, Starzl TE: Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc 20:453-459, 1988.
60Hayashi S, Noguchi K, Yagihashi A, Starzl TE, Iwaki Y: Expression of blood group antigen (A, B, H, Lea, Leb) on liver allografts. Transplant Proc 24:2567-2568, 1992.
61Manez R, Kobayashi M, Takaya S, Bronsther O, Kramer D, Bonet H, Iwaki Y, Fung JJ, Demetris AJ, Starzl TE: Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc 25:888-890, 1993.
62Manez R, White LT, Kusne S, Martin M, Demetris AJ, Starzl TE, Duquesnoy RJ: Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 25:908-909, 1993.
63Starzl TE, Demetris A, Trucco M: HLA matching and the point system. Clin Transplant 7:353-356, 1993.
64Lyne JC, Vivas CA, Shapiro R, Scantlebury VP, Hakala TR, Starzl TE, Jordan ML: Cadaveric renal transplantation against a positive historical crossmatch under tacrolimus immunosuppression: long-term follow-up. Transplant Proc 29:312, 1997.
65Marino IR, Weber T, Esquivel CO, Kang YG, Starzl TE, Duquesnoy RJ: Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation. Transplant Proc 1087-1089, 1988.
66Marino IR, Weber T, Kang YG, Esquivel CO, Starzl TE, Duquesnoy RJ: HLA alloimmunization and blood requirements in orthotopic liver transplantation. Transplant Proc 21:789-791, 1989.
67Ramsey G, Cornell FW, Hahn LF, Fonzi F, Starzl TE: Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies. Transplant Proc 21:3531, 1989.
68Kobayashi M, Yagihashi A, Manez R, Takaya S, Noguchi K, Konno A, Kita Y, Yoshida Y, Terasawa K, Starzl TE, Iwaki Y: Post transplant donor specific T-lymphocytotoxic antibodies in liver transplant patients with a positive crossmatch. Transplant Proc 24:2510-2511, 1992.
69Kobayashi M, Yagihashi A, Noguchi K, Terasawa K, Konno A, Hayashi S, Starzl TE, Iwaki Y: HLA-DR matching effect in orthotopic liver transplantation under FK506. Transplants Proc 25:228-229, 1993.
70Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartman GG, Murase N, Bronsther O, Manez R, Fung JJ, Iwatsuki S, Starzl TE, Demetris AJ: The lymphocytotoxic crossmatch in liver transplantation: A clinicopathologic analysis. Transplant Proc 23:3021-3022, 1991.
71Starzl TE, Demetris AJ, Trucco M: Matching and the black recipient. Transplant Proc 25:2450-2451, 1993.
72Furuya T, Murse N, Nakamura K, Woo J, Todo S, Demetris AJ, Starzl TE: Preformed antibodies in sensitized recipients: Effect of immunoglobulin titer, class, and specificity on liver and heart allografts. Transplant Proc 25:255-256, 1993.
73Zeevi, A and Pavlick, M and Lombardozzi, S and Banas, R and Rao, AS and Fontes, P and Demetris, AJ and Shapiro, R andJordan, M and Dodson, F and Pham, S and Trucco, M and Fung, J and Starzl, TE (1995) Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. Transplantation Proceedings, 27. pp. 213-215.